(Q33751970)

English

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

29 July 2017

A panel of kallikrein markers can predict outcome of prostate biopsy following clinical work-up: an independent validation study from the European Randomized Study of Prostate Cancer screening, France (English)

1 reference

Europe PubMed Central

29 July 2017

prostate cancer screening

1 reference

based on heuristic

inferred from title

prostate cancer

1 reference

based on heuristic

inferred from title

Arnauld Villers

object named as

Arnauld Villers

5

0 references

object named as

Hans Lilja

6

0 references

object named as

Andrew Vickers

7

0 references

author name string

Amine Benchikh

1

1 reference

Europe PubMed Central

29 July 2017

Caroline Savage

2

1 reference

Europe PubMed Central

29 July 2017

Angel Cronin

3

1 reference

Europe PubMed Central

29 July 2017

Gilles Salama

4

1 reference

Europe PubMed Central

29 July 2017

language of work or name

0 references

publication date

22 November 2010

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

10

1 reference

Europe PubMed Central

29 July 2017

635

1 reference

Europe PubMed Central

29 July 2017

https://scigraph.springernature.com/pub.10.1186/1471-2407-10-635

0 references

The relationship between prostate-specific antigen and prostate cancer risk: the Prostate Biopsy Collaborative Group

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Reducing unnecessary biopsy during prostate cancer screening using a four-kallikrein panel: an independent replication

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

A four-kallikrein panel predicts prostate cancer in men with recent screening: data from the European Randomized Study of Screening for Prostate Cancer, Rotterdam

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Impact of recent screening on predicting the outcome of prostate cancer biopsy in men with elevated prostate-specific antigen: data from the European Randomized Study of Prostate Cancer Screening in Gothenburg, Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Patterns in prostate-specific antigen test use and digital rectal examinations in the Behavioral Risk Factor Surveillance System, 2002-2006.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Screening and prostate-cancer mortality in a randomized European study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Mortality results from a randomized prostate-cancer screening trial

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Statistical methods to correct for verification bias in diagnostic studies are inadequate when there are few false negatives: a simulation study

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Predicting prostate cancer risk through incorporation of prostate cancer gene 3.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

A panel of kallikrein markers can reduce unnecessary biopsy for prostate cancer: data from the European Randomized Study of Prostate Cancer Screening in Göteborg, Sweden

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Clinical utility of the PCA3 urine assay in European men scheduled for repeat biopsy

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

PCA3: a molecular urine assay for predicting prostate biopsy outcome

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Decision curve analysis: a novel method for evaluating prediction models

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Prostate cancer screening between low-income African-American and Caucasian men.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2996396

21 June 2018

Screening men for prostate and colorectal cancer in the United States: does practice reflect the evidence?

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-635

21 January 2018

Use of the prostate-specific antigen test among U.S. men: findings from the 2005 National Health Interview Survey

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-635

21 January 2018

ERSPC: features and preliminary results of France.

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-635

21 January 2018

État des lieux et facteurs de participation à l’étude européenne ERSPC de dépistage randomisé du cancer de la prostate par dosage sérique de l’antigène prostatique spécifique : départements français du Tarn et de l’Hérault

1 reference

https://api.crossref.org/works/10.1186%2F1471-2407-10-635

21 January 2018

Identifiers

10.1186/1471-2407-10-635

1 reference

Europe PubMed Central

29 July 2017

Dimensions Publication ID

0 references

1 reference

Europe PubMed Central

29 July 2017

1 reference

Europe PubMed Central

29 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q33751970&oldid=1856141017"